Nordson reports Q4 sales up 4% to $744M; FY2024 record sales $2.7B; guides FY2025 adjusted EPS $9.70-$10.50

NORDSON CORP

2024-FY EPS reported $8.11 revenue$2,689,921,000

Q4 GAAP EPS $2.12 (down from $2.22 YoY); adjusted EPS $2.78 (up from $2.71 YoY).
Full-year adjusted EPS $9.73 (down from $9.85); EBITDA record $849M (32% of sales).
Organic sales fell 3% in Q4; Industrial Precision Solutions segment down 3% YoY.
Atrion Medical acquisition contributed to Medical & Fluid Solutions segment sales +19%.
Fiscal 2025 guidance: sales $2.75-$2.87B; Q1 adjusted EPS $1.95-$2.15 on seasonally weak quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.